Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

Clinical trial NCT06630624 · RECRUITING

Trial details

NCT number: NCT06630624
Sponsor: M.R. Meijerink
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Liver Metastases Liver Metastasis Colon Cancer

Start date: 2024-07-10
Primary completion: 2029-08-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.